We‘re hiring: PhD Student (f/m/x) 🧬
We are seeking a highly motivated PhD student to investigate cell death mechanisms involved in spontaneous tumor regression!
Apply here:
jobs-uk-koeln.onlyfy.jobs/jo…
🧫🧬🧪🐭
Lisa Werr retweeted
🚀 Latest News: 3rd Cologne Conference on Lung Cancer
🗓️We are thrilled to share updates about the 3rd CCLC, happening 26-27 June 2025!
🔗 Check out our website to see the already confirmed speakers – and stay tuned for more to be announced soon!
cologne-clc.com
Very happy to share our latest work on pulmonary carcinoids published in @JCO_ASCO:
TERT Expression and Clinical Outcome in Pulmonary Carcinoids ascopubs.org/doi/10.1200/JCO…
Thanks to all involved!
@sfb1399 @DTG_Cologne @UKKoeln @charlesrudin @natasharekhtman @m_foll @digenoma
Lisa Werr retweeted
🔬Join our Department! Apply now for this PostDoc opportunity in cancer genetics, cancer cell biology and cancer immunology. 👩🔬🧑🔬
@sfb1399 @DTG_Cologne
jobs-uk-koeln.de/index.php?a…
Lisa Werr retweeted
Our 6th Neuroblastoma UK Research Symposium took place last week, bringing together neuroblastoma research experts from around the world. Thank you to everyone who attended. Find out more about the event here: bit.ly/3VIX0vg
@CRUKCamCentre @CRUKCamPaeds #NBUKSymposium
Lisa Werr retweeted
Meet Zahra ⭐
In our latest Story of Hope, Zahra reflects on her past, overcoming insecurities around the scars left by her treatment for neuroblastoma, and embracing a future filled with ambition and advocacy: solvingkidscancer.org.uk/chi…
Lisa Werr retweeted
Wer am hochaggressiven kleinzelligen #Lungenkrebs erkrankt, erleidet häufig nach einer Chemotherapie einen Rückfall. Erstmals haben Forschende den Grund dafür identifiziert: Bei Rückkehr des Tumors dominiert eine andere Zellpopulation. uk-koeln.de/uniklinik-koeln/…
Happy to share our review:
Telomere maintenance mechanisms in neuroblastoma: new insights and translational implications - EJC Paediatric Oncology ejcped.com/article/S2772-610…
@UKKoeln @UniCologne
#neuroblastoma #telomerase #pediatriconcology
Happy to have contributed to this work - congrats to all involved!
We are happy to share that our paper on drug resistance in Small Cell Lung Cancer (#SCLC) within the @SFB1399 has come out in @Nature today. Congratulations to Julie George, Roman Thomas and colleagues!
Read the paper using the link in the comments below.
#smallcelllungcancer
Lisa Werr retweeted
Successful wrap at the #GPOH2023 Meeting in Frankfurt.
🏆 applause to the three recipients of the Young Scientist Award of the GPOH and Deutsche Kinderkrebsstiftung. Their work is steering us towards future breakthroughs in #Childhhod #Cancer – at Frankfurt, Hesse
Lisa Werr retweeted
125.000-Euro-Spende für kinderonkologische Forschung an der #Uniklinik #Köln: Mit seiner Spende unterstützt der Verein "Leverkusen hilft krebskranken Kindern e.V." ein experimentelles Forschungsprojekt zu Mutationen bei Hochrisiko-Neuroblastomen. Infos: uk-koeln.de/uniklinik-koeln/…
finally 🎓
a huge thanks to to everyone who has accompanied and supported me along the way! @DTG_Cologne @chr_reinhardt @haleat1991 @carina_lorenz @braegelmannlab
Honoured to have received the first presentation prize at the Advances in Neuroblastoma Research Meeting #ANR2023 in Amsterdam
Lisa Werr erhält Vortragspreis: Spontane Regression beim Neuroblastom uk-koeln.de/uniklinik-koeln/… @UniCologne #Kinderonkologie #Uniklinik #Köln
Happy to share our work on "Reliable assessment of telomere maintenance mechanisms in neuroblastoma" published in Cell & Bioscience
rdcu.be/cWgMD
@SpringerNature
Lisa Werr retweeted
NEW ONLINE: extracellular vesicle-mediated transfer of telomeres from antigen-presenting cells to T cells enables chromosome elongation, protection against replicative senescence and long-term immune defence.
PDF: rdcu.be/cVGOX
nature.com/articles/s41556-0…
Happy to share our manuscript @MCT_AACR and thanks a lot to all co-authors!
@chr_reinhardt @DennisPlenker @braegelmannlab @haleat1991 @carina_lorenz @klein_se @kevansf @AliSchram
New Publication from our Department:
CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization.
@werr_li @DennisPlenker @braegelmannlab @carina_lorenz @haleat1991
aacrjournals.org/mct/article…
Lisa Werr retweeted
Congrats to @werr_li and all colleagues on this exciting work! CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization aacrjournals.org/mct/article…



















